Effects of Radiotherapy and Chemotherapy in Stage II Breast Cancer
Author Information
Author(s): C. Blomqvist, K. Tiusanen, I. Elomaal, P. Rissanen, T. Hietanen, E. Heinonen, P. Grohn
Primary Institution: University of Helsinki
Hypothesis
Does the combination of radiotherapy, chemotherapy, and tamoxifen improve outcomes in stage II breast cancer?
Conclusion
Adjuvant chemotherapy improved relapse-free survival, but tamoxifen did not enhance overall survival.
Supporting Evidence
- Chemotherapy improved relapse-free survival compared to radiotherapy alone.
- Tamoxifen improved survival in estrogen receptor positive patients.
- 32% of patients discontinued treatment due to gastrointestinal toxicity.
Takeaway
This study looked at how different treatments for breast cancer work together. It found that while chemotherapy helps prevent cancer from coming back, adding tamoxifen didn't help overall survival.
Methodology
Patients were randomized into four treatment groups: radiotherapy, chemotherapy, both, and both with tamoxifen.
Limitations
High toxicity led to treatment discontinuations and dose reductions in many patients.
Participant Demographics
Mean age was 52 years; 53% were estrogen receptor positive.
Statistical Information
P-Value
P = 0.004
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website